VYNE - VYNE Therapeutics Non-GAAP EPS of -$0.13 beats by $0.02 revenue of $0.13M beats by $0.03M
- VYNE Therapeutics press release ( NASDAQ: VYNE ): Q2 Non-GAAP EPS of -$0.13 beats by $0.02 .
- Revenue of $0.13M (-55.2% Y/Y) beats by $0.03M .
- As of June 30, 2022, VYNE had cash and cash equivalents of $42.8 million.
- Shares -4% PM.
For further details see:
VYNE Therapeutics Non-GAAP EPS of -$0.13 beats by $0.02, revenue of $0.13M beats by $0.03M